Results 331 to 340 of about 9,771,651 (424)

Canadian consensus for the assessment and testing of Lynch syndrome. [PDF]

J Med Genet
Aronson M, Palma L, Semotiuk K, Nuk J, Pollett A, Singh H, Rothenmund H, Racher H, Jessen J, Pautler SE, Rusnak A, Rutka M, Etchegary H, Tiano T, Kaurah P, Dawson L, Hawrysh A, Ward T, Bedard A, Sheffield BS, Lerner-Ellis J, Jacob K, Ferguson S, Kim CA, Chamberlain E, Dornan K, Waldman L, Holter S, Horte J, Hyde A, Kwon J, MacMillan A, O'Loughlin M, Tabori U, Gallinger S, Kim R.   +35 more
europepmc   +1 more source

Clinical Genetics in Pediatric Physical Therapy Practice? The Future

, 2001
Bradley G. Schaefer
openalex   +1 more source

Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence

Molecular Oncology, EarlyView.
The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular
Zuzana Liblova, Dominika Maurencova, Barbora Salovska, Marek Kratky, Tomas Mracek, Zuzana Korandova, Alena Pecinova, Pavla Vasicova, David Rysanek, Ladislav Andera, Ivo Fabrik, Rudolf Kupcik, Pavel Kashmel, Pinky Sultana, Vojtech Tambor, Jiri Bartek, Josef Novak, Marie Vajrychova, Zdenek Hodny   +18 more
wiley   +1 more source

Mainstreaming genomics in the National Health Service in England: a survey to understand preparedness and confidence among paediatricians. [PDF]

BMJ Paediatr Open
Griffiths R, Lewis C.
europepmc   +1 more source

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

Molecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma, Sophia M. Orbach, Kate V. Griffin, Kathryn Kang, Yining Zhang, Rebecca S. Pereles, Ian A. Schrack, Guillermo Escalona, Jacqueline S. Jeruss, Lonnie D. Shea   +9 more
wiley   +1 more source

Navigating sexual orientation and gender identity data privacy concerns in United States genetics practices. [PDF]

J Genet Couns
Zayhowski K, Roth S, Westerfield MJ, Martin MA, Blumen K, Bland HT, McQuaid SW, Mittendorf KF.   +7 more
europepmc   +1 more source

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

Molecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu, Katherine Eason, Suet‐Feung Chin, Paul A. W. Edwards, Raquel Manzano Garcia, Richard Moulange, Jia Wern Pan, Soo Hwang Teo, Sach Mukherjee, Maurizio Callari, Carlos Caldas, Stephen‐John Sammut, Oscar M. Rueda   +12 more
wiley   +1 more source

Ethical and Psychosocial Issues Associated with Genetic Testing for Hereditary Tumor Predisposition Syndromes. [PDF]

Healthcare (Basel)
Hachmeriyan M, Levkova M, Yahya D, Stoyanova M, Dimitrova E.   +4 more
europepmc   +1 more source

Molecular genetics of breast cancer: Possible clinical implication

, 2002
Mirjana Branković-Magić, Radmila Janković, Sinisa Radulovic   +2 more
openalex   +2 more sources